SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IPIC
IPIC 0.00010000.0%Aug 15 3:35 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: muddphudd who wrote (1204)5/5/1998 6:58:00 PM
From: margaret foley  Read Replies (2) of 1359
 


TYPE: 424B3
SEQUENCE: 1
DESCRIPTION: PROSPECTUS SUPPLEMENT

Filed Pursuant to Rule 424(b)(3) of the
Securities Act of 1933, as Amended
Registration Statement No. 333-40315

INTERNEURON PHARMACEUTICALS, INC.

PROSPECTUS SUPPLEMENT DATED MAY 5, 1998
TO REOFFER PROSPECTUS DATED NOVEMBER 14, 1997

This Prospectus Supplement (the "Supplement") is a supplement and
should be read in conjunction with the Reoffer Prospectus dated November 14,
1997 ("Reoffer Prospectus"). Of the Shares offered for resale by the Selling
Stockholders pursuant to the Reoffer Prospectus, the initial vesting cycle of an
aggregate of 225,000 Shares subject to restricted stock awards granted under
1997 Equity Incentive Plan (the "Plan") was originally scheduled to commence in
January 1998. In accordance with certain provisions of the Plan providing for
the automatic extension of vesting of Shares in the event of and during a
"Black-Out Period," as defined in the Plan, the initial vesting cycle for these
225,000 Shares was extended to a period commencing May 6, 1998.

EDGAR Alert: INTERNEURON PHARMACEUTICALS INC 424B3

The date of this Prospectus Supplement is May 5, 1998
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext